Aurobindo Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '25
Dec '24
Sep '24
Jun '24
Mar '24
Total Qtr Revenue cr
8,516.93
8,135.81
7,932.07
7,787.95
7,715.77
Other Income Qtr Cr134.81157.29136.00220.93135.62
Operating Revenues Qtr8,382.127,978.527,796.077,567.027,580.15

*All values are in Cr.

Operating Expenses Qtr
6,590.20
6,400.54
6,229.93
5,947.45
5,907.34
Operating Profit Qtr
1,791.92
1,577.98
1,566.14
1,619.57
1,672.81
EBITDA Qtr Cr
1,926.73
1,735.27
1,702.14
1,840.50
1,686.32
Depreciation Qtr
444.43
418.53
382.28
404.18
354.33
Net Profit Qtr
903.47
845.81
817.38
919.22
908.75
Basic EPS Qtr
15.56
14.56
14.00
15.69
15.51
Open Demat Account
+91 -

Open Demat Account
+91 -